The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEVG.L Share News (EVG)

  • There is currently no data for EVG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Tekcapital fundraise; Kromek wins US government order

Wed, 25th May 2022 22:02

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

ASA International Group PLC - Weybridge, Surrey-based microfinance lender - Says ASA Pakistan receives Microfinance Banking licenses from the State Bank of Pakistan. "This is a very important development for the Group. Once we receive the approval to use the licence, it finally will enable us to further strengthen and expand our business in Pakistan by mobilising savings in addition to loans over time," says Chief Executive Officer Dirk Brouwer.

----------

Tekcapital PLC - the London-based intellectual property investor - Raises GBP2 million from placing of 8.0 million shares at 25 pence each, undertaken by its broker SP Angel Corporate Finance LLP. Will use funds for building inventory of MicroSalt, SaltMe crisps, and wireless chargers for Lucyd Lyte smartglasses, as well as capital expenditure to enhance Guident's remote monitoring and control centre.

----------

East Star Resources PLC - gold and copper exploration company focused on Kazakhstan - Starts helicopter electromagnetic survey at Rudny Altai volcanogenic massive sulphine licenses in Eastern Kazakhstan. Expects it to take 40-50 days, with data and technical review and targeting to follow. "HEM surveying is highly effective in direct detection of conductive sulphide deposits in which large conductivity contrasts exist between the orebodies and host rocks. It is the same style survey that was used to discover Havieron, the Greatland Gold and Newcrest gold-copper discovery in Western Australia," says Chief Executive Officer Alex Walker.

----------

Eleco PLC - London-based construction software specialist - In the four months ended April 30, revenue drops to GBP8.9 million from GBP9.3 million a year before, as recurring revenue is up 8% year-on-year to GBP5.4 million, making up around 60% of total revenue. Profit is in line with expectations, firm says. Confident of delivering results in line with market expectations for 2022. "As previously stated, our total reported revenue growth will temporarily soften during our transition to higher value and predictable recurring revenue. We are operating in a very exciting and attractive market and our software is key to meet the growing demands of the built environment, which is under pressure to deliver projects more efficiently and supporting the broader ESG agenda," the company says.

----------

Franchise Brands PLC - Manchester-based owner of ChipsAway, Willow Pumps and Metro Rod brands - Plans to integrate direct labour organisations across UK, to "harmonise" some of Filta UK's DLO business with Willow Pumps. "There are considerable synergies and opportunities in the range of core services of the two DLO businesses, as well as with the Metro Rod franchise network, in particular pump servicing, drainage and fats oils and grease management. These services are very complementary in terms of the customer base, with significant opportunities to cross-sell the now extended range of services to all existing and new customers," the firm says. Will buy out earn-out consideration for its acquisition of Willow Pumps by giving cash payment of GBP1.3 million to its former managing director.

----------

River & Mercantile Group PLC - London-based asset manager - Following FCA approval for its takeover by Assetco PLC, its last day of trading is expected to be June 13, with the acquisition becoming effective the day after, and RMG shares to be cancelled on June 15. Confirms intention to return GBP190 million to its shareholders via B share scheme, with a record date of June 1.

----------

Gresham House Energy Storage Fund PLC - London head-quartered battery storage fund - Intends to raise GBP150 million in the issue of new shares at 145p each, will use proceeds to fund its existing pipeline. Jefferies International Ltd is the sole global coordinator, bookrunner and financial adviser for the transaction.

----------

Kromek Group PLC - Sedgefield, England-based detection technology supplier - Receives order worth USD695,000 from a US federal entity for its D3S-ID wearable nuclear radiation detector, to be delivered in the coming months. The order is a repeat order, having already been awarded a USD1.6 million two-year contract last September. "Being awarded a repeat order for this product from this important customer is a great endorsement. With the volatility of the current geopolitical environment, we are receiving heightened demand for our CBRN solutions, from new and existing customers, as governments become increasingly aware of the need to enhance their real-time threat monitoring," says Chief Executive Officer Arnab Basu.

----------

Evgen Pharma PLC- Cheshire, England-based drug development company - Announces collaboration with Francesco Marampon, a professor at the Universita Sapienza di Roma to investigate potential radiosensitisation effects of its lead asset, SFX-01. "This new collaboration with Prof. Marampon's group aims to gain further insights into the striking effects seen with SFX-01 in combination with radiotherapy. If radiosensitisation is a feature of SFX-01, this could be an important step forward in the treatment of cancers requiring radiotherapy," says Chief Executive Officer Huw Jones.

----------

Mineral & Financial Investments Ltd - Cayman Islands-based investment company - Says Ascendant Resources completes over USD9.0 million of project expenditures at Lagoa Salgada project and paid M&FI subsidiary TH Crestgate an additional USD1.0 million. This fulfils the first phase of earn-in conditions to increase its effective ownership interest from 25% to 50% in the Lagoa Salgada VMS project in Portugal, the company says. "We are thrilled by the outcomes of the development work conducted at Lagoa Salgada since Ascendant's involvement through its earn-in agreement reached in August 2018 with TH Crestgate, now a wholly-owned subsidiary of M&FI. On the exploration front, we believe the yield of tonnage to resources has been exceptional which suggests significant resource growth still to come and on the technical front we are seeing better results than initially expected across the board," says Chief Executive Officer Jacques Vaillancourt.

----------

Bluebird Merchant Ventures Ltd - British Virgin Islands-based gold development company focused on Korea - Applies for two-year extension at the exploration period of mining permit at Batangas Gold project in the Philippines. !The company's Batangas Gold Project has been under care and maintenance since 2016. In recent months there have been strong indications of a more favourable policy in the Philippines towards responsible mining and which has now presented an opportunity for the company to revive the gold project," the firm explains.

----------

Arbuthnot Banking Group PLC - London-based private and commercial lender - Says has seen a strong start to the year, as the Bank of England base rate rises are expected to contribute to increased revenue. Loan balances including leased assets at April 30 were up 3% from the end of 2021 to USD2.06 billion. Assets under management were USD1.35 billion, broadly flat from the end of December.

----------

By Elizabeth Winter; elizabethwinter@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
25 Apr 2024 20:57

TRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast trading well

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
4 Apr 2024 17:24

TRADING UPDATES: Northcoders launches bootcamp; Schroder invests

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
19 Mar 2024 19:47

EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
27 Feb 2024 15:59

Evgen Pharma finds evidence of SFX-01 activity in colon cancer models

(Alliance News) - Evgen Pharma PLC on Tuesday said it found further evidence of SFX-01 activity in models of colon cancer.

Read more
19 Feb 2024 11:45

Evgen Pharma shares up on studies into SFX-01 product progressing well

(Alliance News) - Evgen Pharma PLC on Monday said the studies into its SFX-01 product were progressing positively regarding its activity in Glioblastoma cells.

Read more
9 Feb 2024 18:53

TRADING UPDATES: Apax opts against lifting offer; DCI enters loan deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
9 Feb 2024 17:02

LONDON MARKET CLOSE: FTSE 100 falls at end of tepid week

(Alliance News) - Stock prices in London closed lower on Friday, with the FTSE 100's losing streak extending to three days, as sentiment in Europe remains tetchy despite a largely stellar start to the day in New York.

Read more
16 Jan 2024 18:59

IN BRIEF: Evgen partner raises USD17.4 million to support pipeline

Evgen Pharma PLC - clinical stage drug development company developing sulforaphane-based medicines - Notes that its partner in autism spectrum disorder and other neurodevelopmental disorders Stalicla SA has announced that it has raised USD17.4 million, inclusive of a credit facility. This is to to support programmes on STP1, Stalicla's first asset in ASD, and a further asset in substance use disorders together with a biosampling and patient identification study in ASD. Evgen says it continues to work with Stalicla on delivery of a milestone payment for SFX-01 (Stalicla's STP2). Evgen says both parties are engaged in analysis and interpretation of Evgen's recent Phase 1b healthy volunteer PK/PD study and the implications for a future phase 2 trial in ASD. Evgen says it will provide updates on the status of the programme in "due course" and has not anticipated any milestone payments from Stalicla in its financial forecasting.

Read more
22 Dec 2023 18:06

IN BRIEF: Evgen appoints Toni Hanninen as permanent CFO

Evgen Pharma PLC - clinical stage drug development company developing sulforaphane-based medicines - Appoints Toni Hanninen as permanent chief financial officer, adding that he will now join the board as a director. Hanninen was appointed as interim CFO in September, having previously worked at Faron Pharmaceuticals Ltd. His permanent appointment becomes effective from January 1. Evgen also confirms that non-executive director, Susan Clement-Davies, will be retiring from the board.

Read more
31 Oct 2023 14:38

TRADING UPDATES: Acuity RM wins contract; Georgia Capital ups earnings

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday, and not separately reported by Alliance News:

Read more
26 Oct 2023 11:08

Evgen upbeat on start of glioblastoma research project

(Sharecast News) - Clinical-stage drug developer Evgen Pharma announced on Thursday that it has partnered with Dr Marjolein Geurts, a neuro-oncologist at Erasmus University Medical Centre, to start a ground-breaking research initiative in glioblastoma.

Read more
19 Oct 2023 19:39

IN BRIEF: Evgen showcases importance of new enteric-coated formulation

Evgen Pharma PLC - Cheshire, England-based clinical stage drug developer - Highlights article published in respected industry publication the Medicine Maker, by its Chief Business Officer, Helen Kuhlman. The article, entitled the Sulforaphane Promise, focuses on the recent study of Evgen's new enteric-coated tablet formulation, and why enteric coatings are of particular importance for a stabilised complex such as SFX-01 that releases highly biologically active sulforaphane. The SFX-01 complex is vulnerable to breakdown in acid conditions and the enteric coat prevents acid attack in the stomach, releasing the drug in the ideal region - the small bowel. It also discusses the pharmacodynamic and pharmacokinetic data from the recent study, demonstrating the improvements of the tablet formulation over previous formulations of SFX-01.

Read more
5 Sep 2023 14:22

Evgen Pharma hires interim CFO from Faron, chair to retire this month

(Alliance News) - Evgen Pharma on Tuesday said Non-Executive Chair Barry Clare will retire at its next board meeting, and announced the hiring of interim Chief Financial Officer Toni Hanninen.

Read more
15 Aug 2023 10:01

Evgen Pharma says trial shows new SFX-01 drug formulation is safe

(Alliance News) - Evgen Pharma PLC on Tuesday said final data from a trial of its SFX-01 therapy has shown a new formulation of the drug is safe.

Read more
2 Aug 2023 10:28

IN BRIEF: Evgen Pharma shares drop on ending of license agreement

Evgen Pharma PLC - Cheshire, England-based clinical stage drug development company focused on developing sulforaphane-based medicines - Terminates the patent and know-how license agreement for its Sulforadex sulforaphane stabilisation technology with partner JuvLife Ltd. The exclusive rights will be returned in the final quarter of 2023. The already received upfront payment is non-refundable.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.